Palmi Atlason

Intellectual Property Manager at Coripharma
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
IS
Languages
  • English Native or bilingual proficiency
  • Icelandic Native or bilingual proficiency
  • German Limited working proficiency
  • Danish Limited working proficiency

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • Iceland
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Intellectual Property Manager
      • Aug 2022 - Present
    • Finland
    • Government Administration
    • 300 - 400 Employee
    • Scientific Officer
      • Jul 2010 - Sep 2022

      Scientific Officer in the Classification and Prioritisation Unit of the directorate of Risk Management. Identification and prioritisation of substances of potential concern for human health and the environment. Extensive knowledge of REACH and CLP Regulations Scientific Officer in the Classification and Prioritisation Unit of the directorate of Risk Management. Identification and prioritisation of substances of potential concern for human health and the environment. Extensive knowledge of REACH and CLP Regulations

    • United Kingdom
    • Higher Education
    • 700 & Above Employee
    • Postdoctoral Researcher
      • Dec 2007 - May 2010

      Postdoctoral research in neuropharmacology investigating the structure, function and ligand binding properties of the kainate subtype of ligand-gated ion channels. Extensive use of protein chemistry, molecular cloning and radioligand binding assays Postdoctoral research in neuropharmacology investigating the structure, function and ligand binding properties of the kainate subtype of ligand-gated ion channels. Extensive use of protein chemistry, molecular cloning and radioligand binding assays

    • Biotechnology Research
    • 100 - 200 Employee
    • Research Assistant
      • Jul 2001 - Sep 2004

      Developing in vivo assays for evaluating drug safety and efficacy. Cancer research studying expression of genes in tumorigenic tissue. Developing in vivo assays for evaluating drug safety and efficacy. Cancer research studying expression of genes in tumorigenic tissue.

Education

  • University of Oxford
    Doctor of Philosophy (Ph.D.), Neuropharmacology
    2004 - 2007
  • Háskóli Íslands
    Bachelor’s Degree, Cell/Cellular and Molecular Biology
    1999 - 2001

Community

You need to have a working account to view this content. Click here to join now